5/A

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: April 2, 2012
Period of Report: October 25, 2007
Accession Number: 0001437749-12-003218

View Document ↗ View on SEC.gov ↗